Company / Assets per Share
Mineralys Therapeutics, Inc. Assets per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.24
FY2024
5-year range
$4.24 / $22.15
FY2022-FY2024
Trend
-39.0%
vs FY2023
Sector context
#158 of 210
Health Care
What the data says
Mineralys Therapeutics, Inc.'s assets per share of $4.24 is lower than 75% of companies in the Health Care sector (FY2024). Declined from $22.15 to $4.24 over the past 2 years.
Based on SEC 10-K filings.
4.24 in FY2024.
Declined from $22.15 to $4.24 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 210This company $4.24 Sector average $353.15
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2024, assets per share decreased 39.0% year-over-year.
- Ranks #158 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.24 | -39.0% |
| FY2023 | $6.95 | -68.6% |
| FY2022 | $22.15 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026